New Treatment Award

Each year WORLDSymposium recognizes important achievements in therapy for lysosomal diseases. In 2017 one new treatment was recognized for achieving regulatory approval. The WORLDSymposium 2017 New Treatment Award went to migalastat (Galafold™) which provided clinical data meriting approval by the European Medicines Agency and European Commission in 2016.